This statistic shows the average life expectancy in Europe for those born in 2024, by gender and region. The average life expectancy in Western Europe was 79 years for males and 84 years for females in 2024. Additional information on European life expectancy The difference in life expectancy seen between men and women across all European regions is in line with the global trends of women outliving men, on average. The average life expectancy at birth worldwide by income group shows that the gender life expectancy gap is not only a consistent trend across countries, but also income groups. Moreover, the higher life expectancy for those in high income groups may help to explain the lower average life expectancy for those born in Eastern Europe where average incomes are generally lower than other European regions. Although income and length of life are not directly correlated, higher income individuals are generally able to afford access to superior nutrition and healthcare as well as having leisure time for exercise. That said, current trends in the increases in life expectancy worldwide by country between 1970 and 2017 suggest economic growth will lead to larger increases in life expectancy. Those increases are less likely to occur to such a degree in the more developed regions of Europe where Italy, Spain, France, Switzerland, Iceland and Austria all rank in the top 20 countries with the highest life expectancy.

As of 2023, the countries with the highest life expectancy included Switzerland, Japan, and Spain. As of that time, a new-born child in Switzerland could expect to live an average of **** years. Around the world, females consistently have a higher average life expectancy than males, with females in Europe expected to live an average of *** years longer than males on this continent. Increases in life expectancy The overall average life expectancy in OECD countries increased by **** years from 1970 to 2019. The countries that saw the largest increases included Turkey, India, and South Korea. The life expectancy at birth in Turkey increased an astonishing 24.4 years over this period. The countries with the lowest life expectancy worldwide as of 2022 were Chad, Lesotho, and Nigeria, where a newborn could be expected to live an average of ** years. Life expectancy in the U.S. The life expectancy in the United States was ***** years as of 2023. Shockingly, the life expectancy in the United States has decreased in recent years, while it continues to increase in other similarly developed countries. The COVID-19 pandemic and increasing rates of suicide and drug overdose deaths from the opioid epidemic have been cited as reasons for this decrease.

In 2024, the average life expectancy in the world was 71 years for men and 76 years for women. The lowest life expectancies were found in Africa, while Oceania and Europe had the highest. What is life expectancy?Life expectancy is defined as a statistical measure of how long a person may live, based on demographic factors such as gender, current age, and most importantly the year of their birth. The most commonly used measure of life expectancy is life expectancy at birth or at age zero. The calculation is based on the assumption that mortality rates at each age were to remain constant in the future. Life expectancy has changed drastically over time, especially during the past 200 years. In the early 20th century, the average life expectancy at birth in the developed world stood at 31 years. It has grown to an average of 70 and 75 years for males and females respectively, and is expected to keep on growing with advances in medical treatment and living standards continuing. Highest and lowest life expectancy worldwide Life expectancy still varies greatly between different regions and countries of the world. The biggest impact on life expectancy is the quality of public health, medical care, and diet. As of 2022, the countries with the highest life expectancy were Japan, Liechtenstein, Switzerland, and Australia, all at 84–83 years. Most of the countries with the lowest life expectancy are mostly African countries. The ranking was led by the Chad, Nigeria, and Lesotho with 53–54 years.

In 2024, life expectancy at birth in Europe was 79 years, compared with the low of 62.8 in 1950 and 1951. During this time period, life expectancy increased fastest between the 1950s and mid 1960s, with the rate of improvement slowing since then.

The average for 2022 based on 27 countries was 77.18 years. The highest value was in Sweden: 81.5 years and the lowest value was in Latvia: 69.8 years. The indicator is available from 1960 to 2022. Below is a chart for all countries where data are available.

As defined by the INSEE, healthy life expectancy is the average life in good health - that is, without irreversible limitation of activity in daily life or incapacities - of a fictitious generation subject to the conditions of mortality and morbidity prevailing that year. It characterizes mortality and morbidity regardless of the age structure. In 2021, the healthy life expectancy of French men was **** years, while that of men in Europe was *****years.

On average, women live almost 6 years more than men in France. In 2024, female life expectancy at birth in France reached **** years compared to ** years for males. In 2023, life expectancy in France, regardless of gender, was ***** years. Thus, France is one of the countries in the world with the highest life expectancy. Women outlive men According to the source, there are differences in life expectancy between men and women in France. In 2004, female life expectancy in France was ****, compared to ** years for males. Since then, life expectancy for both genders has been evolving similarly. When life expectancy decreased slightly in 2015, it affected both men and women. Similarly, when life expectancy increased. But one aspect remained the same: male life expectancy remains lower than female life expectancy. This difference has been seen not only in France. In Europe, females are expected to live longer than men in every region. While women in France have a longer life expectancy, they are also expected to have a higher number of healthy life years. In 2013, a study from Eurostat showed that French women had several expected healthy years of ****, compared to ** years for men. An aging population Like other Western countries, France has an aging population. French citizens aged 65 years and older are now more than the French aged from 0 to 14 years old. The median age of the population in the country has been increasing since the nineties, while the share of seniors reached almost ** percent of the population in 2013.

A global phenomenon, known as the demographic transition, has seen life expectancy from birth increase rapidly over the past two centuries. In pre-industrial societies, the average life expectancy was around 24 years, and it is believed that this was the case throughout most of history, and in all regions. The demographic transition then began in the industrial societies of Europe, North America, and the West Pacific around the turn of the 19th century, and life expectancy rose accordingly. Latin America was the next region to follow, before Africa and most Asian populations saw their life expectancy rise throughout the 20th century.

Objective: While Hungary is often reported to have the highest incidence and mortality rates of lung cancer, until 2018 no nationwide epidemiology study was conducted to confirm these trends. The objective of this study was to estimate the occurrence of lung cancer in Hungary based on a retrospective review of the National Health Insurance Fund (NHIF) database.Methods: Our retrospective, longitudinal study included patients aged ≥20 years who were diagnosed with lung cancer (ICD-10 C34) between 1 Jan 2011 and 31 Dec 2016. Age-standardized incidence and mortality rates were calculated using both the 1976 and 2013 European Standard Populations (ESP).Results: Between 2011 and 2016, 6,996 – 7,158 new lung cancer cases were recorded in the NHIF database annually, and 6,045 – 6,465 all-cause deaths occurred per year. Age-adjusted incidence rates were 115.7–101.6/100,000 person-years among men (ESP 1976: 84.7–72.6), showing a mean annual change of − 2.26% (p = 0.008). Incidence rates among women increased from 48.3 to 50.3/100,000 person-years (ESP 1976: 36.9–38.0), corresponding to a mean annual change of 1.23% (p = 0.028). Age-standardized mortality rates varied between 103.8 and 97.2/100,000 person-years (ESP 1976: 72.8–69.7) in men and between 38.3 and 42.7/100,000 person-years (ESP 1976: 27.8–29.3) in women.Conclusion: Age-standardized incidence and mortality rates of lung cancer in Hungary were found to be high compared to Western-European countries, but lower than those reported by previous publications. The incidence of lung cancer decreased in men, while there was an increase in incidence and mortality among female lung cancer patients.

This dataset provides values for RETIREMENT AGE MEN reported in several countries. The data includes current values, previous releases, historical highs and record lows, release frequency, reported unit and currency.

For most of the world, throughout most of human history, the average life expectancy from birth was around 24. This figure fluctuated greatly depending on the time or region, and was higher than 24 in most individual years, but factors such as pandemics, famines, and conflicts caused regular spikes in mortality and reduced life expectancy. Child mortality The most significant difference between historical mortality rates and modern figures is that child and infant mortality was so high in pre-industrial times; before the introduction of vaccination, water treatment, and other medical knowledge or technologies, women would have around seven children throughout their lifetime, but around half of these would not make it to adulthood. Accurate, historical figures for infant mortality are difficult to ascertain, as it was so prevalent, it took place in the home, and was rarely recorded in censuses; however, figures from this source suggest that the rate was around 300 deaths per 1,000 live births in some years, meaning that almost one in three infants did not make it to their first birthday in certain periods. For those who survived to adolescence, they could expect to live into their forties or fifties on average. Modern figures It was not until the eradication of plague and improvements in housing and infrastructure in recent centuries where life expectancy began to rise in some parts of Europe, before industrialization and medical advances led to the onset of the demographic transition across the world. Today, global life expectancy from birth is roughly three times higher than in pre-industrial times, at almost 73 years. It is higher still in more demographically and economically developed countries; life expectancy is over 82 years in the three European countries shown, and over 84 in Japan. For the least developed countries, mostly found in Sub-Saharan Africa, life expectancy from birth can be as low as 53 years.

Mortality from all cancers, directly age-standardised rate, persons, under 75 years, 2004-08 (pooled) per 100,000 European Standard population by Local Authority by local deprivation quintile. Local deprivation quintiles are calculated by ranking small areas (Lower Level Super Output Areas (LSOAs)) within each Local Authority based on their Index of Multiple Deprivation 2007 (IMD 2007) deprivation score, and then grouping the LSOAs in each Local Authority into five groups (quintiles) with approximately equal numbers of LSOAs in each. The upper local deprivation quintile (Quintile 1) corresponds with the 20% most deprived small areas within that Local Authority. The mortality rates have been directly age-standardised using the European Standard Population in order to make allowances for differences in the age structure of populations. There are inequalities in health. For example, people living in more deprived areas tend to have shorter life expectancy, and higher prevalence and mortality rates of most cancers. Cancer accounts for nearly 30% of all deaths among men in England every year and nearly 25% of deaths among women every year1. Reducing inequalities in premature mortality from all cancers is a national priority, as set out in the Department of Health’s Vital Signs Operating Framework 2008/09-2010/112 and the PSA Delivery Agreement 183. However, existing indicators for premature cancer mortality do not take deprivation into account. This indicator has been produced in order to quantify inequalities in cancer mortality by deprivation. This indicator has been discontinued and so there will be no further updates. Legacy unique identifier: P01368

BackgroundIn Europe, men have lower rates of attempted suicide compared to women and at the same time a higher rate of completed suicides, indicating major gender differences in lethality of suicidal behaviour. The aim of this study was to analyse the extent to which these gender differences in lethality can be explained by factors such as choice of more lethal methods or lethality differences within the same suicide method or age. In addition, we explored gender differences in the intentionality of suicide attempts.Methods and FindingsMethods. Design: Epidemiological study using a combination of self-report and official data. Setting: Mental health care services in four European countries: Germany, Hungary, Ireland, and Portugal. Data basis: Completed suicides derived from official statistics for each country (767 acts, 74.4% male) and assessed suicide attempts excluding habitual intentional self-harm (8,175 acts, 43.2% male).Main Outcome Measures and Data Analysis. We collected data on suicidal acts in eight regions of four European countries participating in the EU-funded “OSPI-Europe”-project (www.ospi-europe.com). We calculated method-specific lethality using the number of completed suicides per method * 100 / (number of completed suicides per method + number of attempted suicides per method). We tested gender differences in the distribution of suicidal acts for significance by using the χ2-test for two-by-two tables. We assessed the effect sizes with phi coefficients (φ). We identified predictors of lethality with a binary logistic regression analysis. Poisson regression analysis examined the contribution of choice of methods and method-specific lethality to gender differences in the lethality of suicidal acts.Findings Main ResultsSuicidal acts (fatal and non-fatal) were 3.4 times more lethal in men than in women (lethality 13.91% (regarding 4106 suicidal acts) versus 4.05% (regarding 4836 suicidal acts)), the difference being significant for the methods hanging, jumping, moving objects, sharp objects and poisoning by substances other than drugs. Median age at time of suicidal behaviour (35–44 years) did not differ between males and females. The overall gender difference in lethality of suicidal behaviour was explained by males choosing more lethal suicide methods (odds ratio (OR) = 2.03; 95% CI = 1.65 to 2.50; p < 0.000001) and additionally, but to a lesser degree, by a higher lethality of suicidal acts for males even within the same method (OR = 1.64; 95% CI = 1.32 to 2.02; p = 0.000005). Results of a regression analysis revealed neither age nor country differences were significant predictors for gender differences in the lethality of suicidal acts. The proportion of serious suicide attempts among all non-fatal suicidal acts with known intentionality (NFSAi) was significantly higher in men (57.1%; 1,207 of 2,115 NFSAi) than in women (48.6%; 1,508 of 3,100 NFSAi) (χ2 = 35.74; p < 0.000001).Main limitations of the studyDue to restrictive data security regulations to ensure anonymity in Ireland, specific ages could not be provided because of the relatively low absolute numbers of suicide in the Irish intervention and control region. Therefore, analyses of the interaction between gender and age could only be conducted for three of the four countries. Attempted suicides were assessed for patients presenting to emergency departments or treated in hospitals. An unknown rate of attempted suicides remained undetected. This may have caused an overestimation of the lethality of certain methods. Moreover, the detection of attempted suicides and the registration of completed suicides might have differed across the four countries. Some suicides might be hidden and misclassified as undetermined deaths.ConclusionsMen more often used highly lethal methods in suicidal behaviour, but there was also a higher method-specific lethality which together explained the large gender differences in the lethality of suicidal acts. Gender differences in the lethality of suicidal acts were fairly consistent across all four European countries examined. Males and females did not differ in age at time of suicidal behaviour. Suicide attempts by males were rated as being more serious independent of the method used, with the exceptions of attempted hanging, suggesting gender differences in intentionality associated with suicidal behaviour. These findings contribute to understanding of the spectrum of reasons for gender differences in the lethality of suicidal behaviour and should inform the development of gender specific strategies for suicide prevention.

It is only in the past two centuries where demographics and the development of human populations has emerged as a subject in its own right, as industrialization and improvements in medicine gave way to exponential growth of the world's population. There are very few known demographic studies conducted before the 1800s, which means that modern scholars have had to use a variety of documents from centuries gone by, along with archeological and anthropological studies, to try and gain a better understanding of the world's demographic development. Genealogical records One such method is the study of genealogical records from the past; luckily, there are many genealogies relating to European families that date back as far as medieval times. Unfortunately, however, all of these studies relate to families in the upper and elite classes; this is not entirely representative of the overall population as these families had a much higher standard of living and were less susceptible to famine or malnutrition than the average person (although elites were more likely to die during times of war). Nonetheless, there is much to be learned from this data. Impact of the Black Death In the centuries between 1200 and 1745, English male aristocrats who made it to their 21st birthday were generally expected to live to an age between 62 and 72 years old. The only century where life expectancy among this group was much lower was in the 1300s, where the Black Death caused life expectancy among adult English noblemen to drop to just 45 years. Experts assume that the pre-plague population of England was somewhere between four and seven million people in the thirteenth century, and just two million in the fourteenth century, meaning that Britain lost at least half of its population due to the plague. Although the plague only peaked in England for approximately eighteen months, between 1348 and 1350, it devastated the entire population, and further outbreaks in the following decades caused life expectancy in the decade to drop further. The bubonic plague did return to England sporadically until the mid-seventeenth century, although life expectancy among English male aristocrats rose again in the centuries following the worst outbreak, and even peaked at more than 71 years in the first half of the sixteenth century.

Global life expectancy at birth has risen significantly since the mid-1900s, from roughly 46 years in 1950 to 73.2 years in 2023. Post-COVID-19 projections There was a drop of 1.7 years during the COVID-19 pandemic, between 2019 and 2021, however, figures resumed upon their previous trajectory the following year due to the implementation of vaccination campaigns and the lower severity of later strains of the virus. By the end of the century it is believed that global life expectancy from birth will reach 82 years, although growth will slow in the coming decades as many of the more-populous Asian countries reach demographic maturity. However, there is still expected to be a wide gap between various regions at the end of the 2100s, with the Europe and North America expected to have life expectancies around 90 years, whereas Sub-Saharan Africa is predicted to be in the low-70s. The Great Leap Forward While a decrease of one year during the COVID-19 pandemic may appear insignificant, this is the largest decline in life expectancy since the "Great Leap Forward" in China in 1958, which caused global life expectancy to fall by almost four years between by 1960. The "Great Leap Forward" was a series of modernizing reforms, which sought to rapidly transition China's agrarian economy into an industrial economy, but mismanagement led to tens of millions of deaths through famine and disease.

BackgroundSmoking is the main risk factor for most of the leading causes of death. Cessation is the single most important step that smokers can take to improve their health. With the aim of informing policy makers about decisions on future tobacco control strategies, we estimated time and age trends in smoking cessation in Europe between 1980 and 2010.MethodsData on the smoking history of 50,228 lifetime smokers from 17 European countries were obtained from six large population-based studies included in the Ageing Lungs in European Cohorts (ALEC) consortium. Smoking cessation rates were assessed retrospectively, and age trends were estimated for three decades (1980–1989, 1990–1999, 2000–2010). The analyses were stratified by sex and region (North, East, South, West Europe).ResultsOverall, 21,735 subjects (43.3%) quit smoking over a total time-at-risk of 803,031 years. Cessation rates increased between 1980 and 2010 in young adults (16–40 years), especially females, from all the regions, and in older adults (41–60 years) from North Europe, while they were stable in older adults from East, South and West Europe. In the 2000s, the cessation rates for men and women combined were highest in North Europe (49.9 per 1,000/year) compared to the other regions (range: 26.5–32.7 per 1,000/year). A sharp peak in rates was observed for women around the age of 30, possibly as a consequence of pregnancy-related smoking cessation. In most regions, subjects who started smoking before the age of 16 were less likely to quit than those who started later.ConclusionsOur findings suggest an increasing awareness on the detrimental effects of smoking across Europe. However, East, South and West European countries are lagging behind North Europe, suggesting the need to intensify tobacco control strategies in these regions. Additional efforts should be made to keep young adolescents away from taking up smoking, as early initiation could make quitting more challenging during later life.

IntroductionBetween 2021 and 2023, a project was funded in order to explore the mortality burden (YLL–Years of Life Lost, excess mortality) of COVID-19 in Southern and Eastern Europe, and Central Asia.MethodsFor each national or sub-national region, data on COVID-19 deaths and population data were collected for the period March 2020 to December 2021. Unstandardized and age-standardised YLL rates were calculated according to standard burden of disease methodology. In addition, all-cause mortality data for the period 2015–2019 were collected and used as a baseline to estimate excess mortality in each national or sub-national region in the years 2020 and 2021.ResultsOn average, 15–30 years of life were lost per death in the various countries and regions. Generally, YLL rates per 100,000 were higher in countries and regions in Southern and Eastern Europe compared to Central Asia. However, there were differences in how countries and regions defined and counted COVID-19 deaths. In most countries and sub-national regions, YLL rates per 100,000 (both age-standardised and unstandardized) were higher in 2021 compared to 2020, and higher amongst men compared to women. Some countries showed high excess mortality rates, suggesting under-diagnosis or under-reporting of COVID-19 deaths, and/or relatively large numbers of deaths due to indirect effects of the pandemic.ConclusionOur results suggest that the COVID-19 mortality burden was greater in many countries and regions in Southern and Eastern Europe compared to Central Asia. However, heterogeneity in the data (differences in the definitions and counting of COVID-19 deaths) may have influenced our results. Understanding possible reasons for the differences was difficult, as many factors are likely to play a role (e.g., differences in the extent of public health and social measures to control the spread of COVID-19, differences in testing strategies and/or vaccination rates). Future cross-country analyses should try to develop structured approaches in an attempt to understand the relative importance of such factors. Furthermore, in order to improve the robustness and comparability of burden of disease indicators, efforts should be made to harmonise case definitions and reporting for COVID-19 deaths across countries.

Period when first generation current smokers started smoking by gender and European location of residence (restricted to those who migrated after age 25).

In 2024, the average life expectancy for those born in more developed countries was 76 years for men and 82 years for women. On the other hand, the respective numbers for men and women born in the least developed countries were 64 and 69 years. Improved health care has lead to higher life expectancy Life expectancy is the measure of how long a person is expected to live. Life expectancy varies worldwide and involves many factors such as diet, gender, and environment. As medical care has improved over the years, life expectancy has increased worldwide. Introduction to health care such as vaccines has significantly improved the lives of millions of people worldwide. The average worldwide life expectancy at birth has steadily increased since 2007, but dropped during the COVID-19 pandemic in 2020 and 2021. Life expectancy worldwide More developed countries tend to have higher life expectancies, for a multitude of reasons. Health care infrastructure and quality of life tend to be higher in more developed countries, as is access to clean water and food. Africa was the continent that had the lowest life expectancy for both men and women in 2023, while Oceania had the highest for men and Europe and Oceania had the highest for women.

Cumulative event rates from modeling simulation at 5, 10, 20, 30 and 40 years, %.